azacitidine and Fibrosarcoma

azacitidine has been researched along with Fibrosarcoma in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19907 (41.18)18.7374
1990's1 (5.88)18.2507
2000's4 (23.53)29.6817
2010's5 (29.41)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baek, JM; Bin, BH; Brito, S; Chae, S; Choi, MA; Heo, H; In, KR; Jang, D; Jo, H; Kang, MA; Kim, DO; Kim, JR; Kim, ST; Lee, JS; Lee, MG; Park, H1
Antonicelli, F; Diederich, M; Doliwa, C; Dufer, J; Poplineau, M; Schnekenburger, M; Trussardi-Régnier, A1
Antonicelli, F; Brassart-Pasco, S; Diederich, M; Dufer, J; Kosciarz, A; Poplineau, M; Schnekenburger, M; Trussardi-Régnier, A1
Kim, SJ; Yu, SM2
Kim, DH; Kwon, HJ; Shim, JS1
Cvetkovic, I; Harhaji, L; Markovic, M; Miljkovic, D; Sajic, M; Trajkovic, V; Vuckovic, O1
Sengupta, P; Smith, BD; Wang, L; Widom, R; Xu, Y1
Culp, LA; Kogerman, P; Sy, MS1
Kiningham, KK; Lin, SM; St Clair, DK; Zhao, Y1
Karon, M; Lee, T; Monparler, RL1
Goodman, J; Karon, M; Momparler, RL1
Avila, F; Karon, M; Lee, T; Momparler, RL; Siegel, S1
Benedict, WF; Khwaja, TA1
Goodman, J; Momparler, RL1
Hamada, J; Hosokawa, M; Ishikawa, M; Kobayashi, H; Okada, F1
Frost, P; LeGrue, SJ; Simcik, W1

Other Studies

17 other study(ies) available for azacitidine and Fibrosarcoma

ArticleYear
Loss of the dermis zinc transporter ZIP13 promotes the mildness of fibrosarcoma by inhibiting autophagy.
    Scientific reports, 2019, 10-21, Volume: 9, Issue:1

    Topics: Animals; Autophagy; Azacitidine; Cation Transport Proteins; Cell Death; Cell Line; Dermis; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferases; Down-Regulation; Ethylenediamines; Fibrosarcoma; Humans; Mice, Knockout; Microtubule-Associated Proteins; Zinc

2019
Epigenetically induced changes in nuclear textural patterns and gelatinase expression in human fibrosarcoma cells.
    Cell proliferation, 2013, Volume: 46, Issue:2

    Topics: Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; Cell Nucleus; Chromatin; Chromatin Assembly and Disassembly; Decitabine; Disease Progression; DNA Methylation; Epigenesis, Genetic; Fibrosarcoma; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Image Cytometry; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neoplasm Metastasis; Neoplasm Proteins

2013
The DNA hypomethylating agent, 5-aza-2'-deoxycytidine, enhances tumor cell invasion through a transcription-dependent modulation of MMP-1 expression in human fibrosarcoma cells.
    Molecular carcinogenesis, 2015, Volume: 54, Issue:1

    Topics: Azacitidine; Cell Line, Tumor; Cell Movement; Chromatin Assembly and Disassembly; Decitabine; DNA Methylation; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Promoter Regions, Genetic; Sp1 Transcription Factor; Sp3 Transcription Factor

2015
DNA-hypomethylating agent, 5'-azacytidine, induces cyclooxygenase-2 expression via the PI3-kinase/Akt and extracellular signal-regulated kinase-1/2 pathways in human HT1080 fibrosarcoma cells.
    International journal of oncology, 2015, Volume: 47, Issue:4

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Fibrosarcoma; Fluorescent Antibody Technique; Humans; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction

2015
5-Azacytidine regulates matrix metalloproteinase-9 expression, and the migration and invasion of human fibrosarcoma HT1080 cells via PI3-kinase and ERK1/2 pathways.
    International journal of oncology, 2016, Volume: 49, Issue:3

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Methylation; Epigenesis, Genetic; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Phosphorylation

2016
Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells.
    Oncogene, 2004, Mar-04, Volume: 23, Issue:9

    Topics: Azacitidine; beta Catenin; Cell Line, Tumor; Chromatin; Chromatin Assembly and Disassembly; Cytoskeletal Proteins; Decitabine; Desmoplakins; DNA-Binding Proteins; Enzyme Inhibitors; Fibrosarcoma; gamma Catenin; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Reporter; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Lymphoid Enhancer-Binding Factor 1; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; RNA, Messenger; Trans-Activators; Transcription Factors; Transcriptional Activation

2004
5-Aza-2'-deoxycytidine and paclitaxel inhibit inducible nitric oxide synthase activation in fibrosarcoma cells.
    European journal of pharmacology, 2004, Feb-06, Volume: 485, Issue:1-3

    Topics: Animals; Azacitidine; Cell Line, Tumor; Decitabine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrosarcoma; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Paclitaxel

2004
Collagen alpha1(I) gene (COL1A1) is repressed by RFX family.
    The Journal of biological chemistry, 2005, Jun-03, Volume: 280, Issue:22

    Topics: Animals; Azacitidine; Base Sequence; Binding Sites; Blotting, Western; Cell Line, Tumor; Cell Nucleus; Collagen; Collagen Type I; Collagen Type I, alpha 1 Chain; DNA Methylation; DNA-Binding Proteins; Dose-Response Relationship, Drug; Exons; Fibrosarcoma; Genes, Dominant; Humans; Interferon-gamma; Lentivirus; Models, Biological; Models, Genetic; Molecular Sequence Data; Mutation; Nuclear Proteins; Peptides; Plasmids; Promoter Regions, Genetic; Rats; Regulatory Factor X Transcription Factors; Regulatory Factor X1; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sulfites; Trans-Activators; Transcription Factors; Transcription, Genetic

2005
Counter-selection for over-expressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model.
    Oncogene, 1997, Sep-18, Volume: 15, Issue:12

    Topics: 3T3 Cells; Animals; Antigens, CD; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Transformed; Cell Survival; Cell Transformation, Neoplastic; Decitabine; Fibrosarcoma; Genes, ras; Humans; Hyaluronan Receptors; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Metastasis; Oncogene Proteins v-sis; Oncogenes; Retroviridae Proteins, Oncogenic; Transfection

1997
Overexpression of MnSOD protects murine fibrosarcoma cells (FSa-II) from apoptosis and promotes a differentiation program upon treatment with 5-azacytidine: involvement of MAPK and NFkappaB pathways.
    Antioxidants & redox signaling, 2001, Volume: 3, Issue:3

    Topics: Actins; Animals; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Caspase 3; Caspases; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Fibrosarcoma; Kinetics; MAP Kinase Signaling System; Mice; Mice, Inbred C3H; Mitogen-Activated Protein Kinases; MyoD Protein; NF-kappa B; Superoxide Dismutase; Transfection; Tumor Cells, Cultured

2001
Cellular phosphorylation of 1-beta-D-arabinofuranosylcytosine 5-azacytidine with intact fibrosarcoma and leukemic cells.
    Cancer research, 1975, Volume: 35, Issue:9

    Topics: Animals; Azacitidine; Binding, Competitive; Cells, Cultured; Cricetinae; Cytarabine; Cytidine; Deoxycytidine; Drug Resistance; Fibrosarcoma; Kinetics; Leukemia, Experimental; Mice; Phosphorus; Sarcoma, Experimental

1975
In vitro biochemical and cytotoxicity studies with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine in combination.
    Cancer research, 1975, Volume: 35, Issue:10

    Topics: Antineoplastic Agents; Azacitidine; Cell Division; Cells, Cultured; Cytarabine; DNA, Neoplasm; Drug Combinations; Fibrosarcoma; Time Factors

1975
Effect of tRNA from 5-azacytidine-treated hamster fibrosarcoma cells on protein synthesis in vitro in a cell-free system.
    Biochemical pharmacology, 1976, Feb-15, Volume: 25, Issue:4

    Topics: Animals; Azacitidine; Cell-Free System; Cricetinae; Enzyme Inhibitors; Fibrosarcoma; Protein Biosynthesis; Rabbits; Reticulocytes; RNA, Neoplasm; RNA, Transfer

1976
A new hamster fibrosarcoma model for in vitro/in vivo evaluation of cancer chemotherapeutic agents.
    Medical and pediatric oncology, 1976, Volume: 2, Issue:3

    Topics: Ancitabine; Animals; Antineoplastic Agents; Azacitidine; Cell Division; Cell Line; Cells, Cultured; Clone Cells; Cricetinae; Cytarabine; Disease Models, Animal; Drug Therapy, Combination; Female; Fibrosarcoma; Mesocricetus; Sarcoma, Experimental

1976
In vitro cytotoxic and biochemical effects of 5-aza-2'-deoxycytidine.
    Cancer research, 1977, Volume: 37, Issue:6

    Topics: Azacitidine; Cell Division; Cell Survival; Cells, Cultured; Cytidine; Deoxycytidine; DNA, Neoplasm; Fibrosarcoma; Neoplasm Proteins; Neoplasms, Experimental; RNA, Neoplasm

1977
Changes in the tumorigenic and metastatic properties of tumor cells treated with quercetin or 5-azacytidine.
    International journal of cancer, 1987, Mar-15, Volume: 39, Issue:3

    Topics: Animals; Azacitidine; Cell Line; DNA; Fibrosarcoma; Flavonoids; Methylation; Mice; Mice, Inbred C57BL; Mutagens; Neoplasm Metastasis; Neoplasm Transplantation; Phenotype; Quercetin

1987
Immunological characteristics of immunogenic variants induced in the MCA-F murine fibrosarcoma using 1-methyl-3-nitro-1-nitrosoguanidine, 5-aza-2'-deoxycytidine, or ultraviolet radiation.
    Cancer research, 1989, Aug-01, Volume: 49, Issue:15

    Topics: Animals; Azacitidine; Cross Reactions; Decitabine; Female; Fibrosarcoma; H-2 Antigens; Methylnitronitrosoguanidine; Mice; Mice, Inbred C3H; Phenotype; Tumor Cells, Cultured; Ultraviolet Rays

1989